WHA GroupNews · 2001-12-15 00:00

Jareeporn Jarukornsakul of WHA Group highlights DNA sequencing as a key driver for transforming Thailand's healthcare, biological development, and economy.

Jareeporn Jarukornsakul, Group CEO of WHA Corporation, presented a perspective on the transformative potential of DNA sequencing and genomic medicine. She emphasized its role in revolutionizing healthcare, biological development, and the overall economy of Thailand.

This technology is crucial for advancing precision medicine in Thailand, enabling personalized treatments, accurate disease risk assessment, and the development of a comprehensive Thai genome database, ultimately driving economic growth and innovation beyond traditional sectors.

Fast Facts

·Technology: DNA Sequencing / Genomic Medicine / Precision Medicine
·Key component: DNA (Deoxyribonucleic Acid)
·Human chromosomes: 46 (23 pairs)
·Human genes: Approximately 20,000 - 25,000
·Genetic testing cost: Below 1,000 USD
·Genetic testing speed: 1-2 days
·Key technology: Next-Generation Sequencing
·Application areas: Healthcare, agriculture, economic development

Other

People Mentioned

Jareeporn Jarukornsakul

Chairperson of the Executive Committee and Group Chief Executive Officer at WHA Corporation Public Company Limited

Source

Jareeporn Jarukornsakul of WHA Group highlights DNA sequencing as a key driver for transforming Thailand's healthcare, biological development, and economy.